DHTKD1 and urinary bladder carcinoma: In our previous study, by using of prostate stem cell antigen enhancer (PSCAE), human bladder cancer-specific uroplakin II promoter UP II and the early adenoviral genes E1A, we constructed bladder cancer-specific oncolytic adenovirus Ad-PSCAE-UPII-E1A [17, 18].